- Home
- NAGE vs ATLQ Comparison
NAGE vs ATLQ Comparison
Compare NAGE & ATLQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.06
Company Overview
Basic Information| Metric | NAGE | ATLQ |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 239.0M | 283.6M |
| IPO Year | 2010 | 2026 |
Fundamental Metrics
Financial Performance| Metric | NAGE | ATLQ |
|---|---|---|
| Price | $3.06 | $9.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 346.5K | 10.8K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.82 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $129,423,000.00 | N/A |
| Revenue This Year | $16.51 | N/A |
| Revenue Next Year | $14.58 | N/A |
| P/E Ratio | $33.44 | ★ N/A |
| Revenue Growth | ★ 29.95 | N/A |
| 52 Week Low | $2.87 | $9.96 |
| 52 Week High | $10.05 | $9.98 |
Technical Indicators
Market Signals| Indicator | NAGE | ATLQ |
|---|---|---|
| Relative Strength Index (RSI) | 47.46 | 54.88 |
| Support Level | $2.95 | N/A |
| Resistance Level | $3.61 | N/A |
| Average True Range (ATR) | 0.07 | 0.01 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 48.94 | 100.00 |
Price Performance
Historical Comparison NAGE
ATLQ
About NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About ATLQ JAB Acquisition Corp I Class A Ordinary Shares
JAB Acquisition Corp I is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.